FibroBiologics, Inc., a biotechnology company focused on developing therapeutics for chronic diseases using fibroblasts, announced that its Chief Scientific Officer, Dr. Hamid Khoja, will present ...

Dr. Khoja commented, “Fibroblasts are a critical component of the extracellular matrix with regenerative and immunomodulatory properties. Our presentation will detail the progress we’ve made ...